{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:20:36Z","timestamp":1772612436702,"version":"3.50.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>The aim of this study was to assess the utility of presynaptic dopaminergic imaging using <jats:sup>99m<\/jats:sup>Tc-TRODAT-1 SPECT\/CT and <jats:sup>18<\/jats:sup>F-FDOPA PET\/CT and compare their performance in Parkinson\u2019s disease (PD), Parkinson-plus syndrome (PPS), and essential tremor (ET).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods<\/jats:title>\n            <jats:p>A total of 103 patients (PD = 48, PPS = 19, and ET = 36) were enrolled prospectively. Hoehn and Yahr (H&amp;Y) staging and MDS-UPDRS (Movement Disorder Society\u2013Sponsored Revision of Unified Parkinson\u2019s Disease Rating Scale) were done for PD and PPS cases. All the patients underwent <jats:sup>99m<\/jats:sup>Tc-TRODAT-1 SPECT\/CT and <jats:sup>18<\/jats:sup>F-FDOPA PET\/CT brain scan. The scans were analyzed visually and semiquantitatively. Average pixel count and SUV<jats:sub>mean<\/jats:sub> of the striatum were calculated in SPECT and PET images, respectively, to calculate the specific uptake ratio of striatum (SUR). Comparison of scan findings and SURs among different groups and correlation with clinical characteristics was done.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Symmetrical comma-shaped uptake was seen in bilateral striatum in ET cases with mean SURs significantly higher than in cases of early PD (H&amp;Y stage I and II, n = 37), PD and PPS both on SPECT and PET images (<jats:italic toggle=\"yes\">P<\/jats:italic> \u2264 0.001). The mean SURs between PD and PPS showed no significant difference (SPECT, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.17; PET, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.61). Substantial agreement (weighted \u03ba = 0.659) was found between <jats:sup>99m<\/jats:sup>Tc-TRODAT-1 and <jats:sup>18<\/jats:sup>F-FDOPA for the detection of presynaptic dopaminergic dysfunction. Specific uptake ratio of striatum correlation between SPECT and PET was statistically significant (<jats:italic toggle=\"yes\">r<\/jats:italic> = 0.67; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01). A negative but nonsignificant correlation was found between the SURs and H&amp;Y staging\/MDS-UPDRS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Both <jats:sup>99m<\/jats:sup>Tc-TRODAT-1 SPECT\/CT and <jats:sup>18<\/jats:sup>F-FDOPA PET\/CT showed substantial agreement and proved to be potential imaging biomarker for the detection of dopaminergic dysfunction, thus assisting in differentiating early PD\/PD and PPS from ET cases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000003409","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T23:03:16Z","timestamp":1606258996000},"page":"95-102","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Comparative Performance of 99mTc-TRODAT-1 SPECT\/CT and 18F-FDOPA PET\/CT Imaging in Patients With Parkinson\u2019s Disease, Parkinson-Plus Syndrome, and Essential Tremor"],"prefix":"10.1097","volume":"46","author":[{"given":"Apurva","family":"Sood","sequence":"first","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaya","family":"Shukla","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritu","family":"Shree","sequence":"additional","affiliation":[{"name":"Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakhee","family":"Vatsa","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Modi","sequence":"additional","affiliation":[{"name":"Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhagwant Rai","family":"Mittal","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","year":"1999","journal-title":"Arch Neurol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment","volume":"8","year":"2009","journal-title":"Lancet Neurol"},{"key":"bib3-20250621","first-page":"8","article-title":"Does a long preclinical period occur in Parkinson\u2019s disease?","volume":"46","year":"1991","journal-title":"Geriatrics"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/brain\/awf080","article-title":"The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service","volume":"125","year":"2002","journal-title":"Brain"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1046\/j.1460-9568.1999.00566.x","article-title":"Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson\u2019s disease after administration into the striatum or the lateral ventricle","volume":"11","year":"1999","journal-title":"Eur J Neurosci"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","article-title":"The diagnosis of Parkinson\u2019s disease","volume":"5","year":"2006","journal-title":"Lancet Neurol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1212\/01.wnl.0000325564.38165.d1","article-title":"Historical underpinnings of the term essential tremor in the late 19th century","volume":"71","year":"2008","journal-title":"Neurology"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/archneur.63.8.1100","article-title":"Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor?","volume":"63","year":"2006","journal-title":"Arch Neurol"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/BF01254479","article-title":"Imaging of dopamine transporters in humans with technetium-99m TRODAT-1","volume":"23","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1021\/jm960868t","article-title":"A technetium-99m SPECT imaging agent which targets the dopamine transporter in primate brain","volume":"40","year":"1997","journal-title":"J Med Chem"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archneur.1990.00530120034007","article-title":"The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson\u2019s disease","volume":"47","year":"1990","journal-title":"Arch Neurol"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/jnnp.49.8.853","article-title":"Brain dopamine metabolism in patients with Parkinson\u2019s disease measured with positron emission tomography","volume":"49","year":"1986","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3174\/ajnr.A3971","article-title":"The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2","volume":"36","year":"2015","journal-title":"Am J Neuroradiol"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.2174\/092986706777935258","article-title":"PET tracers for imaging of the dopaminergic system","volume":"13","year":"2006","journal-title":"Curr Med Chem"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MNM.0000000000000802","article-title":"99mTc-TRODAT-1 SPECT\/CT imaging as a complementary biomarker in the diagnosis of parkinsonian syndromes","volume":"39","year":"2018","journal-title":"Nucl Med Commun"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fneur.2018.00156","article-title":"Diagnostic criteria for Parkinson\u2019s disease: from James Parkinson to the concept of prodromal disease","volume":"9","year":"2018","journal-title":"Front Neurol"},{"key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","year":"2017","journal-title":"Mov Disord"},{"key":"bib18-20250621","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","year":"2008","journal-title":"Neurology"},{"key":"bib19-20250621","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","year":"2013","journal-title":"Neurology"},{"key":"bib20-20250621","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/archneur.55.6.823","article-title":"Diagnostic criteria for essential tremor: a population perspective","volume":"55","year":"1998","journal-title":"Arch Neurol"},{"key":"bib21-20250621","first-page":"475","article-title":"(18)F-DOPA PET with and without MRI fusion, a receiver operator characteristics comparison","volume":"2","year":"2012","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"bib22-20250621","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.nicl.2014.05.003","article-title":"Neuroimaging essentials in essential tremor: a systematic review","volume":"5","year":"2014","journal-title":"NeuroImage Clin"},{"key":"bib23-20250621","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00259-008-0989-5","article-title":"Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson\u2019s disease and healthy controls","volume":"36","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib24-20250621","first-page":"439","article-title":"Investigating the dopaminergic synapse in vivo. I. Molecular imaging studies in humans","volume":"18","year":"2007","journal-title":"Rev Neurosci"},{"key":"bib25-20250621","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00259-004-1667-x","article-title":"Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson\u2019s disease","volume":"32","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib26-20250621","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/brain\/120.12.2187","article-title":"Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson\u2019s disease","volume":"120","year":"1997","journal-title":"Brain"},{"key":"bib27-20250621","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12149-015-1042-y","article-title":"Evaluation of (99m)Tc-TRODAT-1 SPECT in the diagnosis of Parkinson\u2019s disease versus other progressive movement disorders","volume":"30","year":"2016","journal-title":"Ann Nucl Med"},{"key":"bib28-20250621","first-page":"393","article-title":"Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson\u2019s disease from healthy subjects","volume":"45","year":"2004","journal-title":"J Nucl Med"},{"key":"bib29-20250621","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s00415-013-7030-z","article-title":"Patients with Parkinson\u2019s disease and scans with (predominant) ipsilateral dopaminergic deficit","volume":"260","year":"2013","journal-title":"J Neurol"},{"key":"bib30-20250621","first-page":"361","article-title":"Decreased dopamine transporter binding ipsilateral to the clinically more affected side in Parkinson\u2019s disease: which side to take?","volume":"7","year":"2016","journal-title":"J Neurol Neurophysiol"},{"key":"bib31-20250621","first-page":"1303","article-title":"Evaluation of early-stage Parkinson\u2019s disease with 99mTc-TRODAT-1 imaging","volume":"42","year":"2001","journal-title":"J Nucl Med"},{"key":"bib32-20250621","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/mds.10482","article-title":"Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations","volume":"18","year":"2003","journal-title":"Mov Disord"},{"key":"bib33-20250621","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/jnnp-2014-310256","article-title":"What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies","volume":"87","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"bib34-20250621","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s100720170040","article-title":"The status of dopamine nerve terminals in Parkinson\u2019s disease and essential tremor: a PET study with the tracer [11-C]FE-CIT","volume":"22","year":"2001","journal-title":"Neurol Sci"},{"key":"bib35-20250621","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/syn.10090","article-title":"Parametric mapping of [18F]FPCIT binding in early stage Parkinson\u2019s disease: a PET study","volume":"45","year":"2002","journal-title":"Synapse"},{"key":"bib36-20250621","doi-asserted-by":"crossref","first-page":"E872","DOI":"10.3390\/cells8080872","article-title":"Molecular imaging of the dopamine transporter","volume":"8","year":"2019","journal-title":"Cell"},{"key":"bib37-20250621","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00415-006-0483-6","article-title":"Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson\u2019s disease","volume":"254","year":"2007","journal-title":"J Neurol"},{"key":"bib38-20250621","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity","volume":"114","year":"1991","journal-title":"Brain"},{"key":"bib39-20250621","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/mds.20855","article-title":"Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson\u2019s disease: a two-year follow-up study","volume":"21","year":"2006","journal-title":"Mov Disord"},{"key":"bib40-20250621","first-page":"207","article-title":"Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson\u2019s disease","volume":"45","year":"2004","journal-title":"J Nucl Med"},{"key":"bib41-20250621","first-page":"999","article-title":"Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson\u2019s disease patients","volume":"44","year":"2003","journal-title":"J Nucl Med"},{"key":"bib42-20250621","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00259-002-0814-5","article-title":"Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson\u2019s disease? For","volume":"29","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib43-20250621","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00259-003-1331-x","article-title":"Usefulness of brain 99mTc-TRODAT-1 SPET for the evaluation of Parkinson\u2019s disease","volume":"31","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib44-20250621","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4","article-title":"In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson\u2019s disease","volume":"47","year":"2000","journal-title":"Ann Neurol"},{"key":"bib45-20250621","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ana.410340331","article-title":"Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson\u2019s disease","volume":"34","year":"1993","journal-title":"Ann Neurol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T21:05:47Z","timestamp":1750539947000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003409","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,24]]}}}